Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Merrill Lynch Bans Trading in Bitcoin-Related Products

Bank of America's (BAC) Merrill Lynch is no longer allowing trading in products connected to bitcoin due to concerns about it.

Best Diets for 2018: U.S. News Releases Annual Ranking

The list of the best diets for 2018 has been unveiled by the U.S. News & World Report and the Mediterranean Diet has been ranked number one.

Sprint Corp Names Michael Combes as President & CFO

Sprint (S) has named Michael Combes as its next President and CFO and it hopes his experience will help with its transformation plans.

Apple’s Battery Replacement Program Could Cost It $10 Billion

Customers opting for a $29 replacement battery over a new iPhone could lose Apple up to 16 million iPhone sales in 2018.

Why Ambev SA (ADR) Stock Could Triple Its Dividend

With the Brazil economy improving and solid cash flow, Ambev can raise its dividend, and Ambev stock could double from here.

Sprint’s CFO Change Is Only the Beginning of Its Terrible Year

Sprint stock is plunging lower on a CFO change, and without a catalyst on the horizon it looks like S stock has a tough year ahead of it.

Australia Plans for Medicinal Marijuana Exports

Australia is planning to legalize medicinal marijuana exports, which will make it the fourth country in the world to do so.

Zynga (ZNGA) a Buy on Robust Earnings Visibility

Currently, Zynga Inc (NASDAQ:ZNGA) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking ZNGA has had from Portfolio Grader for 6 months.

Earnings Momentum Keep Valeant Pharmaceuticals International (VRX) a Buy

Valeant Pharmaceuticals International Inc (NYSE:VRX) ranks in the top 25% of its industry group, Pharmaceuticals, and in the top 25% of its sector group, Health Care, with a market value of $7.2 billion. From an investment attractiveness viewpoint, VRX is ranked in the top quartile of the sector with a ranking of 148 among the 779 companies in the sector; the stock's Portfolio Grader ranking places it 21 among the 134 companies in this industry group, giving it a well above-average position and number 871 in the 5000 company Portfolio Grader company universe.

Flagging Quant Score Make Teva Pharmaceutical Industries (TEVA) a Sell

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is one of 134 companies within the Pharmaceuticals GICS industry group, which is in turn part of the 779 company GICS Health Care sector. The market value of TEVA is $19.3 billion which falls in the top quarter of its industry group. The current Portfolio Grader ranking for TEVA puts it 117 among the 134 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 680 among the 779 companies in the sector, and number 4,039 in the nearly 5,000 company Portfolio Grader universe.

Enough With the Excuses! Tesla Needs a New Magic Trick

Tesla is failing to meet its production scaling problems, but CEO Elon Musk has other tricks, including trucks, up his sleeve.

Why Coffee Lake Matters for Intel Corporation Stock

Intel is actively refreshing its CPU lineup to catch up to AMD. As the company continues to grow revenues, Intel stock still has more upside.

Superb Earnings Growth Keeps Nvidia (NVDA) a Strong Buy

Nvidia Corp (NASDAQ:NVDA) ranks in the top 10% of its industry group, Semiconductors & Semiconductor Equipment, and in the top 10% of its sector group, Information Technology, with a market value of $117.2 billion. From an investment attractiveness vantage point, NVDA is ranked in the top quartile of the sector with a ranking of 84 among the 700 companies in the sector; Portfolio Grader's current ranking for NVDA puts it 14 among the 112 companies in this industry group, putting in the top quartile and number 354 in the 5000 company Portfolio Grader company universe.

Top-End Earnings Growth Makes Microsoft (MSFT) a Strong Buy

The current recommendation of Strong Buy for Microsoft Corp (NASDAQ:MSFT) is the result of using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking MSFT has had from Portfolio Grader for 7 months.

Why Wal-Mart Stores Inc Stock Could Have a Really Rough 2018

Don't sell your WMT stock just yet, but if Loup's newest addition is right, Wal-Mart Stores will run into a brisk headwind.

Freeport-McMoRan (FCX) Upgraded to Buy on Superior Earnings Growth

The current recommendation of Buy for Freeport-McMoRan Inc (NYSE:FCX) has been derived by using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. The shares have been upgraded from a Hold to a Buy in the last week.

The ‘Kernel Bug’ Is a Real Problem for Intel Corporation Stock

Intel says reports of a major design flaw are inaccurate. That doesn't appear to be the case, however - and if Intel is wrong, INTC stock is at risk.

Sales Growth Make Ford Motor (F) a Sell

The current recommendation of Sell for Ford Motor Company (NYSE:F) has been derived by using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. F has maintained this ranking for 4 months.

Ripple Rises Above $3 to Challenge Bitcoin

Ripple is not mined, and it has a centralized blockchain, but its value is exploding against that of bitcoin and other cryptocurrencies.